Filing Details

Accession Number:
0001209191-12-052107
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-07 15:24:41
Reporting Period:
2012-10-24
Filing Date:
2012-11-07
Accepted Time:
2012-11-07 15:24:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463321 Susan Mahony Lilly Corporate Center
Indianapolis IN 46285
Svp & Pres., Lilly Oncology No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-10-24 10,000 $50.45 20,620 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,485 Indirect 401(k)
Common Stock 1,475 Indirect 401(k) - by husband
Common Stock 4,561 Indirect by husband
Footnotes
  1. Reporting person disclaims beneficial ownership of these shares.